Cara Therapeutics | Passività Correnti

Current Liabilities Cambiamento Data
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
Cassava Sciences USD 17.41M 481K 2023-09
Clal Biotechnology ILS 2.91M 173K 2022-12
Compugen USD 10.38M 425K 2023-09
CSL USD 4.61B 278.2M 2023-06
Grifols EUR 2.03B 148.07M 2023-09
Halozyme Therapeutics USD 112.49M 2.69M 2023-12
Pacira USD 97.38M 3.72M 2023-12
RedHill Biopharma USD 28.19M 20.25M 2023-06
Supernus Pharmaceuticals USD 290.2M 2.66M 2023-12



Cara Therapeutics Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.